Sovaldi (sofosbuvir) is a prescription drug used in combination with other drugs to treat chronic hepatitis C virus (HCV). It comes as an oral tablet and pellets. It’s usually taken once daily.
Sovaldi (sofosbuvir) can cause side effects that range from mild to serious. More common side effects include fatigue and headache. If side effects from Sovaldi become difficult to tolerate, talk with ...
In December 2013, the FDA approved Sovaldi a drug developed by Gilead Sciences that promises to do wonders for patients with hepatitis C. Since then, insurers and the government have grown incredibly ...
In San Francisco’s jails, no inmates with hepatitis C are receiving Sovaldi, the breakthrough pill that can cure most patients in an unprecedented amount of time. In California’s prisons, the drug, ...
Blockbuster breakthrough A decade ago, hepatitis C patients were treated with a combination of the drugs peg-interferon and ribavirin, which was dosed over 48 weeks, cured just 50% of patients, and ...
WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than ...
As Gilead Sciences (GILD) launches its next generation Hepatitis C pill, Harvoni, Medicaid programs are bracing for another extraordinary wave of costs, with 70 percent of states implementing coverage ...
The drug Sovaldi, manufactured by Foster City, Calif.-based Gilead Sciences, has garnered a lot of attention for its hefty price tag, coming in at $1,000 per pill, or up to $84,000 for a full course ...
The nation’s largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results